Macrophages in Tumor Microenvironments and the Progression of Tumors
Open accessThe DOI matches its Crossref record; 120 of the 121 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Macrophages are widely distributed innate immune cells that play indispensable roles in the innate and adaptive immune response to pathogens and in-tissue homeostasis. Macrophages can be activated by a variety of stimuli and polarized to functionally different phenotypes. Two distinct subsets of macrophages have been proposed, including classically activated (M1) and alternatively activated (M2) macrophages. M1 macrophages express a series of proinflammatory cytokines, chemokines, and effector molecules, such as IL-12, IL-23, TNF-α, iNOS and MHCI/II. In contrast, M2 macrophages express a wide array of anti-inflammatory molecules, such as IL-10, TGF-β, and arginase1. In most tumors, the infiltrated macrophages are considered to be of the M2 phenotype, which provides an immunosuppressive microenvironment for tumor growth. Furthermore, tumor-associated macrophages secrete many cytokines, chemokines, and proteases, which promote tumor angiogenesis, growth, metastasis, and immunosuppression. Recently, it was also found that tumor-associated macrophages interact with cancer stem cells. This interaction leads to tumorigenesis, metastasis, and drug resistance. So mediating macrophage to resist tumors is considered to be potential therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, many other neoplasms are associated with M2-like TAMs that secrete immunosuppressive cytokines that promote tumor growth and metastasis (8, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, TAMs induce immunosuppression via release of IL-10 and TGF-β, both of which inhibit the development of cytotoxic T cells and NK cells, and may fuel the appearance of more M2-like TAMs at the tumor site (8, 67, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In cancer, tumor-associated macrophages (TAMs) have been known to either promote or hinder neoplasia (8, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
In the citing paper
“In contrast, M2 macrophages (CD163) play an anti-inflammatory and pro-tumor role”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [324]
In the citing paper
“TAMs often exhibit an “M2-like” phenotype [324].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [324]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 2×
“Finally, the monocytes migrate into different tissues and replenish the populations of long-lived tissue-specific macrophages, such as alveolar macrophages and kupffer cells [2, 3].”
BackgroundThe chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534 · cited 4×
“Several studies reporting the use of “antimacrophage” approaches have primarily focused on counteracting monocyte chemokines and receptors as anticancer targets [10, 14, 36, 42].”
BackgroundInfluentialMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“, tumor necrosis factor-α (TNF-α)) [6] (Figure 1).”
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190 · cited 1×
“Finally, the monocytes migrate into different tissues and replenish the populations of long-lived tissue-specific macrophages, such as alveolar macrophages and kupffer cells [2, 3].”
BackgroundNF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745 · cited 1×
“Finally, M2c macrophages are induced by IL-10, transforming growth factor-β (TGF-β), or glucocorticoids (GCs) [7] (Figure 1).”
BackgroundMacrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695 · cited 7×
“M1 macrophages express a series of proinflammatory cytokines, chemokines, and effector molecules, such as IL-12, IL-23, TNF-α, iNOS and MHCI/II.”
BackgroundInfluentialInterleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372 · cited 1×
“IL-23, which is also secreted by M1 macrophages, is associated with the development and expansion of Th17 cells, which can secrete high levels of IL-17 and contribute to inflammatory autoimmune pathologies [17, 18].”
BackgroundCancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343 · cited 1×
“Chemokines, such as CCL17 and CCL22, can prevent the infiltration of cytotoxic T-cells but promote that of Treg and Th2 cells [38, 94].”
Background
Research works printed but not linked: 12
- 2008, Journal of Immunology, 15, 3733
- 2002, American Journal of Pathology, 161, 947, 10.1016/s0002-9440(10)64255-1 · DOI · Paper page
- 2005, Oncology Reports, 14, 425
- 1996, Journal of Immunology, 156, 73
- 1997, Journal of Immunology, 159, 770
- 1995, Journal of Immunology, 154, 1280
- 2000, Cancer Research, 60, 2632
- 1999, International Journal of Cancer, 84, 539
- 1984, Annual Review of Immunology, 2, 283, 10.1146/annurev.iy.02.040184.001435 · doi:10.1146/annurev.iy.02.040184.001435 · Paper page
- 2003, Cancer Research, 63, 8360
- 1995, Cancer Research, 55, 1499
- 2003, Cancer Research, 63, 7853
Cited by
Items 401–500 of 1,000
Meng, L., Lin, B., Wang, B., Feng, K., Hu, D., Wang, L., Cheong, K., Zhao, J., & Li, S. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.05.017 · Cited by 35
Separate roles of IL ‐6 and oncostatin M in mouse macrophage polarization in vitro and in vivo
Dubey, A., Izakelian, L., Ayaub, E. A., Ho, L., Stephenson, K. B., Wong, S. C., Kwofie, K., Austin, R. C., Botelho, F. M., Ask, K., et al. (2017) · Immunology and Cell Biology · doi:10.1111/imcb.1035 · Cited by 35
Immune Checkpoint Inhibitors: Fundamental Mechanisms, Current Status and Future Directions
Younis, A., & Gribben, J. G. (2024) · Immuno · doi:10.3390/immuno4030013 · Cited by 42
Human pathological basis of blood vessels and stromal tissue for nanotechnology
Nishihara, H. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.01.005 · Cited by 35
Effects of Hypoxia in Intestinal Tumors on Immune Cell Behavior in the Tumor Microenvironment
Zhang, L., Wang, S., Wang, Y., Zhao, W., Zhang, Y., Zhang, N., & Xu, H. W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.645320 · Cited by 36
“Hypoxia-induced tumor-derived cytokines, such as IL-10 and transforming growth factor-beta, can induce tumor-associated macrophages to differentiate into M2 macrophages with immunosuppressive effects (25).”
BackgroundCutting edges and therapeutic opportunities on tumor-associated macrophages in lung cancer
Hu, Q., Wu, G., Wang, R., Ma, H., Zhang, Z., & Xue, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1007812 · Cited by 34
“M2a macrophages are mainly stimulated by Th2 cytokines represented by IL-4 and IL-14 (72).”
BackgroundSelf-citationThe Study of the Extracellular Matrix in Chronic Inflammation: A Way to Prevent Cancer Initiation?
Marangio, A., Biccari, A., D’Angelo, E., Sensi, F., Spolverato, G., Pucciarelli, S., & Agostini, M. (2022) · Cancers · doi:10.3390/cancers14235903 · Cited by 37
Hiller, J. G., Brodner, G., & Gottschalk, A. (2013) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2013.10.003 · Cited by 37
Diverse roles of macrophages in intraocular neovascular diseases: a review
Zhou, Y., Yoshida, S., Peng, Y., Kobayashi, Y., Zhang, L.-S., & Tang, L.-S. (2017) · International Journal of Ophthalmology · doi:10.18240/ijo.2017.12.18 · Cited by 38
Zheng, B., Yang, B., Chen, H., Pan, H., Ji, W., Gong, X., Wu, X., Wang, H., & Chang, J. K. (2018) · Biomaterials Science · doi:10.1039/c8bm00218e · Cited by 33
de França, G. M., CARMO, A. F. D., NETO, H. C., de Andrade, A. L. D. L., de Lima, K. C., & Galvão, H. C. (2019) · Brazilian Oral Research · doi:10.1590/1807-3107bor-2019.vol33.0047 · Cited by 33
Xu, J., Zhu, K., Wang, Y., & Chen, J. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04447-7 · Cited by 33
“Indeed, HO-1 expression is implicated in the polarization of macrophages toward a protolerogenic, pro-angiogenic, IL-10-producing M2 phenotype, indicating that HO-1 increases their immunosuppressive role (Hao et al. 2012).”
Background111In-anti-F4/80-A3-1 antibody: a novel tracer to image macrophages
Terry, S. Y. A., Boerman, O. C., Gerrits, D., Franssen, G. M., Metselaar, J. M., Lehmann, S., Oyen, W. J. G., Gerdes, C. A., & Abiraj, K. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3084-8 · Cited by 33
“Although M1 and M2 macrophage phenotypes are not stable as they can change in response to environmental signals [9], TAMs mostly polarize towards the M2 phenotype [10].”
BackgroundMacrophage and osteoclast polarization in bisphosphonate associated necrosis and osteoradionecrosis
Wehrhan, F., Möbius, P., Amann, K., Ries, J., Preidl, R. H. M., Neukam, F. W., & Weber, M. (2017) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2017.02.023 · Cited by 33
“…towards tissue destructive inflammation (M1) or towards wound healing and tissue regeneration (M2) (Allavena and Mantovani, 2012, Cao et al., 2011, Hao et al., 2012, Hirata et al., 2011, Kurahara et al., 2011, Lan et al., 2012, Mantovani et al., 2007, Mantovani et al., 2013, Murray and Wynn,…”
BackgroundMechanisms regulating immune surveillance of cellular stress in cancer
Seelige, R., Searles, S. C., & Bui, J. D. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2597-7 · Cited by 36
“Hypoxia-experiencing tumor cells release higher amounts of ATP, which can serve as a DAMP for inflammasome-induced immune responses [70], as described in the section about “DNA damage”.”
BackgroundInflammation and Cancer: In Medio Stat Nano
Molinaro, R., Corbo, C., Livingston, M. K., Evangelopoulos, M., Parodi, A., Boada, C., Agostini, M., & Tasciotti, E. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867324666170920160030 · Cited by 34
Do Mesenchymal Stem Cells Modulate the Milieu of Reconstructed Bladder Wall?
Pokrywczyńska, M., Jundziłł, A., Bodnar, M., Adamowicz, J., Tworkiewicz, J., Szylberg, Ł., Dębski, R., Marszałek, A., & Drewa, T. A. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-013-0249-7 · Cited by 32
“M1 response with elevated expression of TNF-a, IL1 and IL6 is usually observed in early phases of healing, whereas M2 response with high level of IL-10 and TGFb in later phases (Hao et al. 2012).”
BackgroundInflammatory macrophages in pancreatic acinar cell metaplasia and initiation of pancreatic cancer
Liou, G., & Störz, P. (2015) · Oncoscience · doi:10.18632/oncoscience.151 · Cited by 32
“M1-polarized macrophages not only remove dead or dying cells via phagocytosis, but are also involved in inflammation-mediated tissue remodeling, while M2-polarized macrophages restrain the inflammatory response and also inhibit the T-cell response [1].”
BackgroundTumour growth and immune evasion as targets for a new strategy in advanced cancer
Nicolini, A., Ferrari, P., Rossi, G., & Carpi, A. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0142 · Cited by 33
Zhou, J., Zhang, A., & Liang, F. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s254985 · Cited by 34
Tan, J., Yang, L., Zhao, H., Ai, Y., Ren, L., Zhang, F., Dong, W., Shi, R., Sun, D., & Feng, Y. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113052 · Cited by 36
TNF-α haplotype association with polycystic ovary syndrome – a South Indian study
Deepika, M., Reddy, K. R., Yashwanth, A. L., Rani, V. U., Latha, K. P., & Jahan, P. (2013) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-013-0080-4 · Cited by 36
Sánchez-Reyes, K., Bravo-Cuéllar, A., Hernández-Flores, G., Lerma-Díaz, J. M., Jave-Suárez, L., Gómez-Lomelí, P., de Celis, R., Aguilar-Lemarroy, A., Domínguez-Rodríguez, J., & Ortiz-Lazareno, P. (2014) · BioMed Research International · doi:10.1155/2014/683068 · Cited by 39
“This is important because the presence of M1 or M2 can modify the prognosis of a patient with cancer [7, 15].”
BackgroundZhao, F., Wang, C., Yang, Q., Han, S., Hu, Q., & Fu, Z. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.03.058 · Cited by 32
Zoledronate Causes a Systemic Shift of Macrophage Polarization towards M1 In Vivo
Weber, M., Homm, A., Müller, S., Frey, S., Amann, K., Ries, J., Geppert, C. I., Preidl, R. H. M., Möst, T., Kämmerer, P. W., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031323 · Cited by 32
“In contrast, M2 macrophages are immune-regulatory, contribute to wound healing and tissue repair and promote tumor growth by immunosuppressive features [12,13].”
BackgroundTargeting tumor-associated macrophages in colon cancer: mechanisms and therapeutic strategies
Xiang, J., Wang, J., Xiao, H., Huang, C., Wu, C., Zhang, L., Qian, C., & Xiang, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1573917 · Cited by 31
“This process is facilitated by several chemokines, including CCL3, CCL4, CCL5, CCL22, and CXCL8, which are highly expressed in various tumors and promote TAM migration (90 – 92).”
Liljenfeldt, L., Dieterich, L. C., Dimberg, A., Mangsbo, S. M., & Loskog, A. (2014) · Cancer Gene Therapy · doi:10.1038/cgt.2014.2 · Cited by 31
Yu, Q., Jobin, C., & Thomas, R. M. (2021) · Neoplasia · doi:10.1016/j.neo.2020.12.008 · Cited by 33
Sørensen, M. D., & Kristensen, B. W. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12772 · Cited by 32
Macrophage Dysfunction in Autoimmune Rheumatic Diseases and Atherosclerosis
Герасимова, Е. В., Попкова, Т. В., Gerasimova, D. A., & Kirichenko, T. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094513 · Cited by 32
“express receptors to IL-1, TLR, and co-stimulatory molecules, thus providing induction of the inflammatory response [24].”
BackgroundZhou, Z., Hu, Y., Wu, Y., Qi, Q., Wang, J., Chen, L., & Wang, F. (2022) · Molecular Immunology · doi:10.1016/j.molimm.2022.09.010 · Cited by 31
Nodal promotes the generation of M2 ‐like macrophages and downregulates the expression of IL ‐12
Wang, X., Wang, H., Zhang, F., Guo, Q., Wang, H., Wang, K., Zhang, G., Bu, X., Cai, S., & Du, J. (2013) · European Journal of Immunology · doi:10.1002/eji.201343535 · Cited by 31
Ohashi, W., Hattori, K., & Hattori, Y. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.225540 · Cited by 36
“elicited by anti-inflammatory stimuli, such as glucocorticoid hormones, IL-10, and transforming growth factor-b (TGF-b) (Hao et al., 2012).”
BackgroundNath, A., Pal, R., Singh, L. M., Saikia, H., Rahaman, H., Ghosh, S. K., Mazumder, R., & Sengupta, M. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.02.021 · Cited by 30
Liu, D., Vadgama, J. V., & Wu, Y. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.56128 · Cited by 31
“TNF-α signaling also positively affects immune activation in the tumor microenvironment through a positive feedback mechanism between TNFα levels and M1 macrophage activation [50].”
BackgroundDeveloping Extracellular Matrix Technology to Treat Retinal or Optic Nerve Injury
Ren, T., van der Merwe, Y., & Steketee, M. B. (2015) · eNeuro · doi:10.1523/eneuro.0077-15.2015 · Cited by 31
“…factor- , inducible nitric oxide synthase, and C-X-C motif chemokine 10, while alternatively activated M2-like markers include transforming growth factor- (TGF- ), IL-10, IL-1 receptor antagonist, arginase-1, CD206, and CD163 (Kawamura et al., 2009; Hao et al., 2012; Martinez and Gordon, 2014).”
BackgroundNguyen, H.-Y. T., Vo, B.-H. T., Nguyễn, H. L. T., Bernad, J., Alaeddine, M., Coste, A., Reybier, K., Pipy, B., & Nepveu, F. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.06.002 · Cited by 30
Wang, Z., Chen, C., Ai, J., Shu, J., Ding, Y., Wang, W., Gao, Y., Jia, Y., & Qin, Y. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107227 · Cited by 30
Wu, D., Liu, R., Cen, X., Dong, W., Chen, Q., Lin, J., Wang, X., Ling, Y., Mao, R., Haitao, S., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04248-y · Cited by 30
“As essential components of the innate immune sys-tem and cellular immunity, macrophages maintain tissue homeostasis and play indispensable roles throughout wound healing [27, 28].”
Nanovectors Design for Theranostic Applications in Colorectal Cancer
Rampado, R., Crotti, S., Caliceti, P., Pucciarelli, S., & Agostini, M. (2019) · Journal of Oncology · doi:10.1155/2019/2740923 · Cited by 32
“In particular, M2 polarized tumor-associated macrophages (TAMs) can promote cell proliferation, inhibiting apoptosis and promoting angiogenesis and metastasis, either by direct contact or by the production of immune-modulatory cytokines (e.g., IL-10 and TGF-β ) [7].”
Blood Vessels and Peripheral Nerves as Key Players in Cancer Progression and Therapy Resistance
Roda, N., Blandano, G., & Pelicci, P. G. (2021) · Cancers · doi:10.3390/cancers13174471 · Cited by 32
Bioinformatic Analysis of Immune Significance of RYR2 Mutation in Breast Cancer
Xu, Z., Xiang, L., Wang, R., Xiong, Y., Zhou, H., Gu, H., Wang, J., & Peng, L. (2021) · BioMed Research International · doi:10.1155/2021/8072796 · Cited by 34
“In contrast, M1 macrophages are activated by Th1 cell factors; secrete inducible inductors, such as IL-12, iNOS, and TNF-α; and play a proinflammatory and antitumor role in the tumor microenvironment [29].”
BackgroundWu, S., Yuan, W., Luo, W., Nie, K., Wu, X., Meng, X., Shen, Z., & Wang, X. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13218 · Cited by 29
Alimohammadi, R., Chalbatani, G. M., Alimohammadi, M., Nazari, H. G., Rahimi, A., Mortaz, E., Mossafa, N., Boon, L., Janji, B., & Jalali, S. A. (2022) · Scientific Reports · doi:10.1038/s41598-023-29363-9 · Cited by 29
Professional antigen presenting cells in human herpesvirus 8 infection
Knowlton, E. R., Lepone, L. M., Li, J., Rappocciolo, G., Jenkins, F. J., & Rinaldo, C. R. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00427 · Cited by 31
“IL-13 is an anti-inflammatory, Th2 cytokine that induces alternatively activated (M2) macrophages (Hao et al., 2012).”
BackgroundHow interacting pathways are regulated by miRNAs in breast cancer subtypes
Cava, C., Colaprico, A., Bertoli, G. R., Bontempi, G., Mauri, G., & Castiglioni, I. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1196-1 · Cited by 30
“Recently, it was also found that tumour-associated macrophages interact with CSCs thus leading to tumourigenesis, metastasis, and drug resistance [138].”
BackgroundSeparation of Macrophages Using a Dielectrophoresis-Based Microfluidic Device
Zhang, Y., Wang, S., Chen, J., Yang, F., & Li, G. (2020) · BioChip Journal · doi:10.1007/s13206-020-4207-2 · Cited by 28
Wang, W., Liang, Y., Guan, X., Dong, B., Zhao, M., Wu, J., Tian, X., & Hao, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.618215 · Cited by 30
Obesity and Inflammation: Colorectal Cancer Engines
Malhab, L. J. B., & Abdel‐Rahman, W. M. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467214666210906122054 · Cited by 32
Breast Cancer Tumor Microenvironment and Molecular Aberrations Hijack Tumoricidal Immunity
Lin, H.-J. L., Liu, Y., Lofland, D., & Lin, J. (2022) · Cancers · doi:10.3390/cancers14020285 · Cited by 30
The Role of the NLRP3 Inflammasome in HCC Carcinogenesis and Treatment: Harnessing Innate Immunity
Papadakos, S. P., Dedes, N., Kouroumalis, E., & Theocharis, S. E. (2022) · Cancers · doi:10.3390/cancers14133150 · Cited by 28
“Despite a recent surge in the literature of single cell analyses that demonstrate the existence of TAMs which synchronously express signatures from both the M1 and M2 macrophage clusters [54], TAMs and TANs are classically divided into two subtypes: on the one hand, M1 and N1 secrete IFN-γ and IL-12, potentiating the…”
BackgroundKelly, M. G., Francisco, A. M. C., Cimic, A., Wofford, A., Fitzgerald, N., Yu, J., & Taylor, R. N. (2015) · Reproductive Sciences · doi:10.1177/1933719115570912 · Cited by 28
“Macrophages are multifunctional innate immune cells with an array of essential roles in normal tissue homeostasis, early responses to pathogens, presentation of host and foreign antigens following injury and infection, and resolution of inflammation and wound healing.(2) Macrophages”
BackgroundInfluentialShen, K., Song, Y., Chen, I.-H., Chong, P. C.-S., & Liu, S. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29275 · Cited by 28
“During tumor progression, tumors induce macrophages to differentiate into IL-10producing M2-like TAMs to inhibit CTL anti-tumor responses.(22) Many reports have demonstrated that TAMs are potential immune escape mechanisms of HPV-associated cancer.”
BackgroundModulatory effects of adiponectin on the polarization of tumor-associated macrophages
Peng, J., Tsang, J. Y., Ho, D., Zhang, R., Xiao, H., Li, D., Zhu, J. J., Wang, F., Bian, Z., Lui, V. C. H., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29485 · Cited by 28
“This observation is consistent with reported correlations between the number of TAMs and poor prognosis for other adult malignant tumors such as breast, prostate, ovarian, cervical, esophageal and bladder cancers.(18) Furthermore, the presence of adiponectin (APN) also varied for the different pediatric tumors we inve…”
ResultThomas, F., Donnadieu, E., Charrière, G. M., Jacqueline, C. M., Tasiemski, A., Pujol, P., Renaud, F., Roche, B., Hamede, R., Brown, J. S., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2007066 · Cited by 29
Abulimiti, A., Zhang, X., Shivappa, N., Hébert, J. R., Fang, Y., Huang, C.-Y., Feng, X.-L., Chen, Y., & Zhang, C. (2020) · Nutrients · doi:10.3390/nu12010232 · Cited by 28
“M1 macrophages lead to adipose secretion of several pro-inflammatory cytokines, such as TNF-α, IL-1, and IL-6, contributing to affect the microenvironment of tumor growth [55].”
BackgroundHsiao, C., Lin, Y., Liu, C., Nguyen, H. T., & Chuang, A. E.-Y. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202402864 · Cited by 29
Liu, M., Tang, Y., Yan, M., Zhang, J., Chen, H., & Zhang, Q. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123187 · Cited by 27
Serum levels of the chemokine CCL2 are elevated in malignant pleural mesothelioma patients
Kishimoto, T., Fujimoto, N., Ebara, T., Omori, T., Oguri, T., Niimi, A., Yokoyama, T., Kato, M., Usami, I., Nishio, M., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-6419-1 · Cited by 28
Kim, J., Jeong, S. K., Oh, S. J., Lee, C. G., Kang, Y. R., Jo, W. S., & Jeong, M. H. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5017 · Cited by 27
“Cancer cells can release molecules that induce TAM differentiation into immunosuppressive forms, such as the M2 type, or recruit Tregs in the tumor microenvironment (10,11,16).”
BackgroundJiang, P., & Li, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.835932 · Cited by 30
Tumor immunotherapy: Mechanisms and clinical applications
Nong, C., Guan, P., Li, L., Zhang, H., & Hu, H. (2022) · MedComm – Oncology · doi:10.1002/mog2.8 · Cited by 30
The immune cell infiltrate in the tumour microenvironment of phaeochromocytomas and paragangliomas
Tufton, N., Hearnden, R. J., Berney, D. M., Drake, W. M., Parvanta, L., Chapple, J. P., & Akker, S. A. (2022) · Endocrine Related Cancer · doi:10.1530/erc-22-0020 · Cited by 29
Wang, J., Ling, D., Shi, L., Li, H., Peng, M., Wen, H., Liu, T., Liang, R., Lin, Y., Wei, L., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01149-6 · Cited by 28
“The literature suggests that TAM polarization is closely related to tumorigenesis and modulates the immune microenvironment by releasing various cytokines and chemokines [36].”
BackgroundOncostatin M is overexpressed in skin squamous-cell carcinoma and promotes tumor progression
Simonneau, M., Frouin, É., Huguier, V., Jermidi, C., Jégou, J., Godet, J., Barra, A., Paris, I., Levillain, P., Cordier-Dirikoc, S., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26355 · Cited by 27
Decidua Basalis Mesenchymal Stem Cells Favor Inflammatory M1 Macrophage Differentiation In Vitro
Abumaree, M., Harthy, S. A., Subayyil, A. M. A., Alshabibi, M. A., Abomaray, F., Khatlani, T., Kalionis, B., El-Muzaini, M. F., Jumah, M. A., Jawdat, D. M., et al. (2019) · Cells · doi:10.3390/cells8020173 · Cited by 27
“In addition, M2 macrophages provide an anti-inflammatory microenvironment that is essential for tumor growth and progression [8].”
Madhoun, A. S. A., Kochumon, S., Al‐Rashed, F., Sindhu, S. T. A. K., Thomas, R., Miranda, L., Al‐Mulla, F., & Ahmad, R. (2022) · Cells · doi:10.3390/cells11182879 · Cited by 28
“M1 macrophages are pro-inflammatory, secrete high levels of IL-6, TNF-α, IL-1β, CXCL-9/10, IL-12, and IL-23 but low levels of IL-10, and are predominant in obese adipose tissue [71,72].”
BackgroundPrecision Targeting Strategies in Pancreatic Cancer: The Role of Tumor Microenvironment
Vitorakis, N., Gargalionis, A. N., Papavassiliou, K. A., Adamopoulos, C., & Papavassiliou, A. G. (2024) · Cancers · doi:10.3390/cancers16162876 · Cited by 29
Lorestani, P., Dashti, M., Nejati, N., Habibi, M. A., Askari, M., Robat-Jazi, B., Ahmadpour, S., & Tavakolpour, S. (2024) · Discover Oncology · doi:10.1007/s12672-024-01256-x · Cited by 27
“It is noteworthy that in this paradigm, the tumor-initiating characteristics of murine PC cell lines were intensified by conditioned media from macrophages educated by tumors [59].”
BackgroundMajolo, F., Bitencourt, S., Monteiro, B. W., Haute, G. V., Alves, C., Silva, J., Pintéus, S., Santos, R. C. V., Torquato, H. F. V., Paredes‐Gamero, E. J., et al. (2020) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2020.1753606 · Cited by 27
“Macrophages are important innate immune cells with key roles in the primary response to pathogens and presentation of foreign and self-antigens following infection or injury (Hao et al. 2012).”
BackgroundMacrophage Proinflammatory Responses to Microorganisms and Transplanted Organs
Kloc, M., Uosef, A., Kubiak, J. Z., & Ghobrial, R. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249669 · Cited by 27
“The recruitment of the monocytes to the tumor and their differentiation into TAMs occurs in response to the cytokines and chemokines, such as the high mobility group box protein 1 (HMGB1) alarmin, CCL2, CCL3, CCL4, CCL5, CCL7, CCL8, CXCL12, VEGF, PDGF, and IL-10, produced by the cells present in the tumor [8,23].”
BackgroundJhan, M.-K., Chen, C., Shen, T., Tseng, P., Wang, Y.-T., Satria, R. D., Yu, C.-Y., & Lin, C. (2021) · Cells · doi:10.3390/cells10113181 · Cited by 26
Duarte‐Sanmiguel, S., Salazar‐Puerta, A. I., Panic, A., Dodd, D. J., Francis, C., Alzate‐Correa, D., Ortega‐Pineda, L., Lemmerman, L. R., Rincon‐Benavides, M. A., Dathathreya, K., et al. (2023) · Biomaterials Science · doi:10.1039/d3bm00573a · Cited by 26
Alegranci, P., Ribeiro, L. C. D. A., Ferreira, L. S., Negrini, T. D. C., Maia, D. C. G., Tansini, A., Gonçalves, A. C., Placeres, M. C. P., & Carlos, I. Z. (2013) · Mycopathologia · doi:10.1007/s11046-013-9663-y · Cited by 29
“exhibit cytotoxic activities because of their ability to secrete reactive oxygen species and nitrogen species, in particular nitric oxide [16, 17].”
BackgroundLow, H. B., Png, C. W., Li, C., Wang, D. Y., Wong, S. B. J., & Zhang, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.10980 · Cited by 28
“TGFβ is another important immunosuppressive cytokine produced by TAMs in various tumors [46, 47].”
BackgroundYin, S., Wang, N., Riabov, V., Mossel, D. M., Larionova, I., Schledzewski, K., Trofimova, O., Sevastyanova, T. N., Zajakina, A., Schmuttermaier, C., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32685 · Cited by 26
Saleh, N. A., Rode, M. P., Sierra, J. A., Silva, A. H., Miyake, J. A., Filippin-Monteiro, F. B., & Creczynski‐Pasa, T. B. (2020) · Cytotechnology · doi:10.1007/s10616-020-00440-5 · Cited by 28
Zhuang, Z., Qi, Y., Huang, Q., Zhang, C., Zeng, X., Zhong, Z., Cheng, S., & Zhang, X. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202404381 · Cited by 25
Ngabire, D., Niyonizigiye, I., Patil, M. P., Seong, Y.-A., Seo, Y. B., & Kim, G. (2020) · Journal of Immunology Research · doi:10.1155/2020/1731457 · Cited by 28
“M2 macrophages promote the expansion of tumors by enhancing proliferation [5], metastasis [6], angiogenesis [7], lymphangiogenesis [8], and immunosuppression [9].”
Ha, N., Faraji, F., & Hunter, K. W. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7876-8_17 · Cited by 25
Chen, Z., Zhu, B., Peng, X. X., Li, S., & Zhao, J. (2022) · Biomolecules · doi:10.3390/biom12101491 · Cited by 25
“Macrophages play an indispensable role in the innate and adaptive immunity of the human body [28].”
BackgroundZhang, J., Cui, J., Gao, J., Zhang, D., Lin, D., & Lin, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114246 · Cited by 26
Focus on Pancreatic Cancer Microenvironment
Pratticò, F., & Garajová, I. (2024) · Current Oncology · doi:10.3390/curroncol31080316 · Cited by 26
“…cancer microenvironment, various factors, such as CSF-1, IL-4, IL-13, TGF β and IL-10, promote myeloid progenitor cell differentiation into monocytes and macrophages [89,90], which in turn secrete immunosuppressive cytokines, chemokines and enzymes, such as TGF β , IL-10, CCL17, and CCL22 [91].”
BackgroundNarasimhan, P. B., Akabas, L. H., Tariq, S., Huda, N., Bennuru, S., Sabzevari, H., Hofmeister, R., Nutman, T. B., & Semnani, R. T. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006404 · Cited by 26
Immune System Efficiency in Cancer and the Microbiota Influence
Barbosa, A. M., Gomes-Gonçalves, A., Castro, A. G., & Torrado, E. (2021) · Pathobiology · doi:10.1159/000512326 · Cited by 26
Tumor-associated macrophages derived exosomes; from pathogenesis to therapeutic opportunities
Hadad, S., Khalaji, A., Sarmadian, A. J., Sarmadian, P. J., Janagard, E. M., & Baradaran, B. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112406 · Cited by 24
Wang, K., Zhang, X., Li, A., Qiao, X., & Xu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1545928 · Cited by 29
“Additionally, they exert an immunomodulatory role by secreting cytokines, the complement system, and in fl ammatory response regulation (2).”
Chung, J., Saad, J., Kafri, A., Rossignol, J., Verbrugge, M., & Bakke, J. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1712576 · Cited by 27
“…M1 macrophage state associated with pro-in fl ammatory effects, anti-tumor signals, stimulation of cytotoxic T-cells, secretion of cytokines like interleukin (IL)-12, tumor necrosis factor alpha (TNF-a ), reactive oxygen species (ROS) and essentially activity to kill tumor cells and pathogens (60).”
The Adipocyte–Macrophage Relationship in Cancer: A Potential Target for Antioxidant Therapy
Sanhueza, S., Simón, L., Cifuentes, M., & Quest, A. F. G. (2023) · Antioxidants · doi:10.3390/antiox12010126 · Cited by 24
TRAIL-functionalized gold nanoparticles selectively trigger apoptosis in polarized macrophages
Huang, Y.-J., & Hsu, S. (2017) · Nanotheranostics · doi:10.7150/ntno.20233 · Cited by 24
“TAMs were considered with the same immunosuppressive effects as M2 macrophages in tumor progression [8].”
BackgroundLeber, N., Kaps, L., Yang, A., Aslam, M., Giardino, M., Klefenz, A., Choteschovsky, N., Rosigkeit, S., Mostafa, A., Nuhn, L., et al. (2019) · Macromolecular Bioscience · doi:10.1002/mabi.201900162 · Cited by 24
Curry, J. M., Besmer, D. M., Erick, T. K., Steuerwald, N., Roy, L. D., Grover, P., Rao, S. G., Nath, S., Ferrier, J. W., Reid, R. W., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224309 · Cited by 24
“Interestingly, several genes related to immune system function, such as CCL6 [57], CCL8 [58], MHC class II molecules, and arginase-1 (Arg1) [59] were highly up-regulated in the vaccine + indomethacin treatment group compared to untreated control (Fig 4A).”
BackgroundEnhancement of phagocytosis and cytotoxicity in macrophages by tumor-derived IL-18 stimulation
Henan, X., Toyota, N., Xing, Y., Fujita, Y., Huang, Z., Touma, M., Wu, Q., & Sugimoto, K. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.5.152 · Cited by 26
“In most established tumors, infiltrated macrophages are driven to acquire an M2-type, with a reduced expression of NOS2 and TNF-α (22), to provide an immunosuppressive microenvironment for tumor growth (23, 24).”
BackgroundEngagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
Manara, M. C., Manferdini, C., Cristalli, C., Carrabotta, M., Santi, S., Feo, A. D., Caldoni, G., Pasello, M., Landuzzi, L., Lollini, P., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0440 · Cited by 23
“…produce many pro-in fl ammatory and effector molecules and exert antitumor cytolytic activity, whereas alternatively activated M2-like macrophages are anti-in fl ammatory and promote wound healing, angiogenesis, and tissue remodeling, ultimately favoring tumor invasion and progression (61).”
Targeting OAS3 for reversing M2d infiltration and restoring anti-tumor immunity in pancreatic cancer
Zhang, S., Xu, X., Zhang, K., Lei, C., Xu, Y., Zhang, P., Zhang, Y., Gu, H., Huang, C. L., & Qiu, Z. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03898-w · Cited by 23
Choudhary, M., Safe, S. H., & Malek, G. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.02.015 · Cited by 23
“The M1 macrophages are known for their pro-fibrotic and pro-inflammatory properties whereas, M2 macrophages, are characterized by their immunosuppressive and tissue remodeling properties (38, 69, 70).”
Interleukin-10 Induces Expression of Neuroendocrine Markers and PDL1 in Prostate Cancer Cells
Samiea, A., Yoon, J. S. J., Ong, C. J., Zoubeidi, A., Chamberlain, T. C., & Mui, A. (2020) · Prostate Cancer · doi:10.1155/2020/5305306 · Cited by 24
“IL10 could be produced either by the tumour cells themselves [13, 23–25] or by tumour elicitation of tumour-infiltrating, IL10 producing immune cells [26, 27].”
BackgroundZhou, H., Sun, J., Wu, J., Wei, H., & Zhou, X. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s297571 · Cited by 23
Grazia, A. D., Fusco, D. D., Franzè, E., Colella, M., Strimpakos, G., Salvatori, S., Formica, V., Laudisi, F., Maresca, C., Colantoni, A., et al. (2022) · Cancers · doi:10.3390/cancers14215294 · Cited by 25
“In neoplastic progression two types of macrophage: tumor-killing and tumor-promoting macrophage subpopulations can be present [30,31].”
BackgroundAvila, J. P., Carvalho, B. M., & Coimbra, E. C. (2023) · Cancers · doi:10.3390/cancers15041333 · Cited by 27
“Additionally, the presence of regulatory T-cells (Tregs), tumor-associated macrophages (TAM) of the M2 phenotype, and cancer-associated fibroblasts (CAFs) generates an immunosuppressive TME, which has been attributed to a poor prognosis of various types of cancer [35,36], such as cervical cancer [37,38].”
Background
Metadata
- Authors
- Hao, N.-B., Lü, M.-H., Fan, Y.-H., Cao, Y.-L., Zhang, Z.-R., & Yang, S.-M.
- Affiliations
- Army Medical University (CN)
- Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China
- Biomedical Analysis Center, Third Military Medical University, Chongqing 40038, China
- Corresponding author
- Zhang, Zhi-Ren
- Venue
- Clinical and Developmental Immunology
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-11
- ISSN
- 1740-2522 (ISSN-L)
- 1740-2530
- PMC
- PMC3385963
- OpenAlex
- W2106027870
- Cited by
- 1,003
- References
- 121
- Citations by year
- 2026: 28 · 2025: 52 · 2024: 79 · 2023: 75 · 2022: 81 · 2021: 109 · 2020: 86 · 2019: 60 · 2018: 65 · 2017: 70 · 2016: 73 · 2015: 85 · 2014: 69 · 2013: 68 · 2012: 2
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Clinical and Developmental Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (31170851, 2010CB529406, 2009BA5045)
- National Basic Research Program of China (31170851, 2010CB529406, 2009BA5045)
- Chongqing Science Fund for Distinguished Young Scholars (31170851, 2010CB529406, 2009BA5045)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- tumor-associated macrophages, tumor microenvironment, macrophage polarization, M1 macrophages, M2 macrophages, immunosuppression, tumor angiogenesis, metastasis, cancer stem cells, drug resistance, macrophage-targeted therapy
- MeSH terms
- Animals, Humans, Macrophages, Neoplasms, Disease Progression, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.